Insulin: Eli Lilly cuts price to $35 a month in US after pleas from patients and president

The giant drug company Eli Lilly has reduced the price of its insulins to $35 (£27; €31) a month for the US’s eight million insulin dependent patients with diabetes, after campaigns by patients’ advocates and President Joe Biden.1

Eli Lilly’s insulin prices in the US have risen by 1000% over the past 30 years.2 In his State of the Union speech on 7 February, Biden criticised drug companies for increasing the price of insulin. On 1 March he praised Lilly’s price cut and said other insulin manufacturers should follow suit.

Neither Novo Nordisk nor Sanofi has said whether they …